Small molecule agonist of very late antigen-4 (VLA-4) integrin induces progenitor cell adhesion

Journal of Biological Chemistry

Volumn 288, Issue 27, 2013, Pages 19414-19428

  Vanderslice, Peter ^a   Biediger, Ronald J ^a   Woodside, Darren G ^a   Brown, Wells S ^b   Khounlo, Sayadeth ^a   Warier, Navin D ^a   Gundlach IV, C William ^a   Caivano, Amy R ^a   Bornmann, William G ^b   Maxwell, David S ^b   McIntyre, Bradley W ^b   Willerson, James T ^a   Dixon, Richard A F ^a  

^a ST LUKE S EPISCOPAL HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESION RECEPTORS; CELL-BASED THERAPY; CROSS-REACTIVITY; LIGAND-BINDING SITES; STEM CELL THERAPY; STRUCTURAL MODIFICATIONS; SUBUNIT INTERFACES; SYNTHESIS AND CHARACTERIZATIONS;

ANTIGENS; CELL ADHESION; CELL CULTURE; LIGANDS; MOLECULES; PHOTOREACTIVITY; STEM CELLS; SYNTHESIS (CHEMICAL);

COBALT COMPOUNDS;

STROMAL CELL DERIVED FACTOR 1; TRANSCRIPTION FACTOR; VERY LATE ACTIVATION ANTIGEN 4;

ANTIBODY SPECIFICITY; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL ADHESION; CELL MIGRATION; CELL SPREADING; CONTROLLED STUDY; CROSS REACTION; CRYSTAL STRUCTURE; DRUG ACTIVITY; DRUG STRUCTURE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LIGAND BINDING; MOLECULAR DOCKING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN SYNTHESIS; SHEAR FLOW; SHEAR STRESS; STEM CELL;

AGONIST; CELL ADHESION; CELL THERAPY; FIBRONECTIN; ICAM-1; INTEGRINS; PROGENITOR CELLS; STEM CELLS; VCAM-1; VLA-4;

ANTIGENS, CD11A; CELL ADHESION; CELL MOVEMENT; CHEMOKINE CXCL12; HETEROCYCLIC COMPOUNDS WITH 4 OR MORE RINGS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTEGRIN ALPHA4BETA1; INTEGRIN ALPHA5BETA1; JURKAT CELLS; MODELS, MOLECULAR; STEM CELLS; TISSUE THERAPY; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84880061008     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.479634     Document Type: Article

References (54)

1. Perin, E. C., Dohmann, H. F., Borojevic, R., Silva, S. A., Sousa, A. L., Mesquita, C. T., Rossi, M. I., Carvalho, A. C., Dutra, H. S., Dohmann, H. J., Silva, G. V., Belém, L., Vivacqua, R., Rangel, F. O., Esporcatte, R., Geng, Y. J., Vaughn, W. K., Assad, J. A., Mesquita, E. T., and Willerson, J. T. (2003) Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 107, 2294-2302
2. Schächinger, V., Erbs, S., Elsässer, A., Haberbosch, W., Hambrecht, R., Hölschermann, H., Yu, J., Corti, R., Mathey, D. G., Hamm, C. W., Süselbeck, T., Assmus, B., Tonn, T., Dimmeler, S., Zeiher, A. M., and REPAIRAMI Investigators (2006) Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N. Engl. J. Med. 355, 1210-1221
3. Schächinger, V., Aicher, A., Döbert, N., Röver, R., Diener, J., Fichtlscherer, S., Assmus, B., Seeger, F. H., Menzel, C., Brenner, W., Dimmeler, S., and Zeiher, A. M. (2008) Pilot trial on determinants of progenitor cell recruitment to the infarcted human myocardium. Circulation 118, 1425-1432
4. Liu, J., Narsinh, K. H., Lan, F., Wang, L., Nguyen, P. K., Hu, S., Lee, A., Han, L., Gong, Y., Huang, M., Nag, D., Rosenberg, J., Chouldechova, A., Robbins, R. C., and Wu, J. C. (2012) Early stem cell engraftment predicts late cardiac functional recovery: preclinical insights from molecular imaging. Circ. Cardiovasc. Imaging 5, 481-490
5. Vrtovec, B., Poglajen, G., Lezaic, L., Sever, M., Domanovic, D., Cernelc, P., Socan, A., Schrepfer, S., Torre-Amione, G., Haddad, F., and Wu, J. C. (2013) Effects of intracoronary CD34+ stem cell transplantation in nonis-chemic dilated cardiomyopathy patients: 5-year follow up. Circ. Res. 112, 165-173
6. Chavakis, E., Urbich, C., and Dimmeler, S. (2008) Homing and engraftment of progenitor cells: a prerequisite for cell therapy. J. Mol. Cell. Cardiol. 45, 514-522
7. Hynes, R. O. (1992) Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69, 11-25
8. Coller, B. S. (1997) Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics. J. Clin. Invest. 100, S57-S60
9. Polman, C. H., O'Connor, P. W., Havrdova, E., Hutchinson, M., Kappos, L., Miller, D. H., Phillips, J. T., Lublin, F. D., Giovannoni, G., Wajgt, A., Toal, M., Lynn, F., Panzara, M. A., and Sandrock, A. W. (2006) A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N. Engl. J. Med. 354, 899-910
10. Xiong, J. P., Stehle, T., Zhang, R., Joachimiak, A., Frech, M., Goodman, S. L., and Arnaout, M. A. (2002) Crystal structure of the extracellular segment of integrinαVβ3 in complex with an Arg-Gly-Asp ligand. Science 296, 151-155
11. Lee, J. O., Rieu, P., Arnaout, M. A., and Liddington, R. (1995) Crystal structure of the A domain from the α subunit of integrin CR3 (CD11b/CD18). Cell 80, 631-638
12. Luo, B. H., Carman, C. V., and Springer, T. A. (2007) Structural basis of integrin regulation and signaling. Annu. Rev. Immunol. 25, 619-647
13. Chavakis, E., Aicher, A., Heeschen, C., Sasaki, K., Kaiser, R., El Makhfi, N., Urbich, C., Peters, T., Scharffetter-Kochanek, K., Zeiher, A. M., Chavakis, T., and Dimmeler, S. (2005) Role of β2-integrins for homing and neovascularization capacity of endothelial progenitor cells. J. Exp. Med. 201, 63-72
14. Song, H., Chang, W., Lim, S., Seo, H. S., Shim, C. Y., Park, S., Yoo, K. J., Kim, B. S., Min, B. H., Lee, H., Jang, Y., Chung, N., and Hwang, K. C. (2007) Tissue transglutaminase is essential for integrin-mediated survival of bone marrow-derived mesenchymal stem cells. Stem Cells 25, 1431-1438
15. Chavakis, E., Hain, A., Vinci, M., Carmona, G., Bianchi, M. E., Vajkoczy, P., Zeiher, A. M., Chavakis, T., and Dimmeler, S. (2007) High mobility group box 1 activates integrin-dependent homing of endothelial progenitor cells. Circ. Res. 100, 204-212
16. Schroeter, M. R., Leifheit, M., Sudholt, P., Heida, N. M., Dellas, C., Rohm, I., Alves, F., Zientkowska, M., Rafail, S., Puls, M., Hasenfuss, G., Konstantinides, S., and Schäfer, K. (2008) Leptin enhances the recruitment of endothelial progenitor cells into neointimal lesions after vascular injury by promoting integrin-mediated adhesion. Circ. Res. 103, 536-544
17. Duan, H., Cheng, L., Sun, X., Wu, Y., Hu, L., Wang, J., Zhao, H., and Lu, G. (2006) LFA-1 and VLA-4 involved in human high proliferative potentialendothelial progenitor cells homing to ischemic tissue. Thromb. Haemost. 96, 807-815
18. Teixidó, J., Hemler, M. E., Greenberger, J. S., and Anklesaria, P. (1992) Role of β1 and β2 integrins in the adhesion of human CD34hi stem cells to bone marrow stroma. J. Clin. Invest. 90, 358-367
19. Zhang, S., Shpall, E., Willerson, J. T., and Yeh, E. T. (2007) Fusion of human hematopoietic progenitor cells and murine cardiomyocytes is mediated by α4β1 integrin/vascular cell adhesion molecule-1 interaction. Circ. Res. 100, 693-702
20. Dobaczewski, M., Bujak, M., Zymek, P., Ren, G., Entman, M. L., and Frangogiannis, N. G. (2006) Extracellular matrix remodeling in canine and mouse myocardial infarcts. Cell Tissue Res. 324, 475-488
21. Abbott, J. D., Huang, Y., Liu, D., Hickey, R., Krause, D. S., and Giordano, F. J. (2004) Stromal cell-derived factor-1α plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 110, 3300-3305
22. Du, X. P., Plow, E. F., Frelinger, A. L., 3rd, O'Toole, T. E., Loftus, J. C., and Ginsberg, M. H. (1991) Ligands "activate" integrin αIIbβ3 (platelet GPIIb-IIIa). Cell 65, 409-416
23. Yang, W., Carman, C. V., Kim, M., Salas, A., Shimaoka, M., and Springer, T. A. (2006) A small molecule agonist of an integrin, αLβ2. J. Biol. Chem. 281, 37904-37912
24. Biediger, R. J., Grabbe, V. O., Holland, G. W., Kassir, J. M., Kogan, T. P., Lin, S., Market, R. V., Raju, B. G., Scott, I. L., and Wu, C. (February 27, 2001) N,N-Disubstituted amides that inhibit the binding of integrins to their receptors, U. S. Patent 6,194,448
25. Biediger, R. J., Gundlach, C. W., Market, R. V., Savage,M.M., and Vanderslice, P. (May 24, 2012) Agonists That Enhance Binding of Integrin-expressing Cells to Integrin Receptors, International Patent PCT/US2011/060996
26. Kassir, J. M., Grabbe, V. O., Biediger, R. J., Scott, I. L., Raju, B. G., Ren, K., Market, R. V., Keller, K. M., Lin, S., Kogan, T. P., Krudy, G. A., Chen, Q., Holland, G. W., Maxwell, D. C., You, T. J., Vanderslice, P., West, H., Decker, E. R., Tilton, R., Munsch, C. L., and Dixon, R. A. F. (2000) Book of Abstracts 219th ACS National Meeting, San Francisco, CA, March 26-30, 2000, Abstr. MEDI284, ACS Publications, Washington, D.C.
27. Scott, D., Lee, W.-C., Petter, R. C., and Cornebise, M. (October 7, 2003) Cell adhesion inhibitors, U. S. Patent 6,630,503
28. Vanderslice, P., Ren, K., Revelle, J. K., Kim, D. C., Scott, D., Bjercke, R. J., Yeh, E. T., Beck, P. J., and Kogan, T. P. (1997) A cyclic hexapeptide is a potent antagonist of α4 integrins. J. Immunol. 158, 1710-1718
29. Rose, D. M., Liu, S., Woodside, D. G., Han, J., Schlaepfer, D. D., and Ginsberg, M. H. (2003) Paxillin binding to the α4 integrin subunit stimulates LFA-1 (integrin αLβ2)-dependent T cell migration by augmenting the activation of focal adhesion kinase/proline-rich tyrosine kinase-2. J. Immunol. 170, 5912-5918
30. Woodside, D. G., Kram, R. M., Mitchell, J. S., Belsom, T., Billard, M. J., McIntyre, B. W., and Vanderslice, P. (2006) Contrasting roles for domain 4 of VCAM-1 in the regulation of cell adhesion and soluble VCAM-1 binding to integrin α4β1. J. Immunol. 176, 5041-5049
31. Vanderslice, P., Woodside, D. G., Caivano, A. R., Decker, E. R., Munsch, C. L., Sherwood, S. J., Lejeune, W. S., Miyamoto, Y. J., McIntyre, B. W., Tilton, R. G., and Dixon, R. A. (2010) Potent in vivo suppression of inflammation by selectively targeting the high affinity conformation of integrin α4β1. Biochem. Biophys. Res. Commun. 400, 619-624
32. Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, I. N., and Bourne, P. E. (2000) The Protein Data Bank. Nucleic Acids Res. 28, 235-242
33. Leone, D. R., Giza, K., Gill, A., Dolinski, B. M., Yang, W., Perper, S., Scott, D. M., Lee, W. C., Cornebise, M., Wortham, K., Nickerson-Nutter, C., Chen, L. L., LePage, D., Spell, J. C., Whalley, E. T., Petter, R. C., Adams, S. P., Lobb, R. R., and Pepinsky, R. B. (2003) An assessment of the mechanistic differences between two integrin α4β1 inhibitors, the monoclonal antibody TA-2 and the small molecule BIO5192, in rat experimental autoimmune encephalomyelitis. J. Pharmacol. Exp. Ther. 305, 1150-1162
34. Chen, J., Salas, A., and Springer, T. A. (2003) Bistable regulation of integrin adhesiveness by a bipolar metal ion cluster. Nat. Struct. Biol. 10, 995-1001
35. Arroyo, A. G., García-Pardo, A., and Sánchez-Madrid, F. (1993) A high affinity conformational state on VLA integrin heterodimers induced by an anti-1 chain monoclonal antibody. J. Biol. Chem. 268, 9863-9868
36. Szabo, M. C., Teague, T. K., and McIntyre, B. W. (1995) Regulation of lymphocyte pseudopodia formation by triggering the integrin α4/β1. J. Immunol. 154, 2112-2124
37. Peled, A., Petit, I., Kollet, O., Magid, M., Ponomaryov, T., Byk, T., Nagler, A., Ben-Hur, H., Many, A., Shultz, L., Lider, O., Alon, R., Zipori, D., and Lapidot, T. (1999) Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 283, 845-848
38. Yu, Y., Zhu, J., Mi, L. Z., Walz, T., Sun, H., Chen, J., and Springer, T. A. (2012) Structural specializations of α(4)β(7), an integrin that mediates rolling adhesion. J. Cell Biol. 196, 131-146
39. Irie, A., Kamata, T., Puzon-McLaughlin, W., and Takada, Y. (1995) Critical amino acid residues for ligand binding are clustered in a predicted β-turn of the third N-terminal repeat in the integrin α4 and α5 subunits. EMBO J. 14, 5550-5556
40. Ruiz-Velasco, N., Guerrero-Esteo, M., Briskin, M. J., and Teixidó, J. (2000) The α(4) integrin subunit Tyr(187) has a key role in α(4)β(7)-dependent cell adhesion. J. Biol. Chem. 275, 7052-7059
41. Pepinsky, R. B., Mumford, R. A., Chen, L. L., Leone, D., Amo, S. E., Riper, G. V., Whitty, A., Dolinski, B., Lobb, R. R., Dean, D. C., Chang, L. L., Raab, C. E., Si, Q., Hagmann, W. K., and Lingham, R. B. (2002) Comparative assessment of the ligand and metal ion binding properties of integrins α9β1 and α4β1. Biochemistry 41, 7125-7141
42. Obara, M., Kang, M. S., and Yamada, K. M. (1988) Site-directed mutagenesis of the cell-binding domain of human fibronectin: separable, synergis-tic sites mediate adhesive function. Cell 53, 649-657
43. Newham, P., Craig, S. E., Seddon, G. N., Schofield, N. R., Rees, A., Edwards, R. M., Jones, E. Y., and Humphries, M. J. (1997) α4 integrin binding interfaces on VCAM-1 and MAdCAM-1. Integrin binding footprints identify accessory binding sites that play a role in integrin specificity. J. Biol. Chem. 272, 19429-19440
44. Björklund, M., Aitio, O., Stefanidakis, M., Suojanen, J., Salo, T., Sorsa, T., and Koivunen, E. (2006) Stabilization of the activated αMβ2 integrin by a small molecule inhibits leukocyte migration and recruitment. Biochemistry 45, 2862-2871
45. Maiguel, D., Faridi, M. H., Wei, C., Kuwano, Y., Balla, K. M., Hernandez, D., Barth, C. J., Lugo, G., Donnelly, M., Nayer, A., Moita, L. F., Schürer, S., Traver, D., Ruiz, P., Vazquez-Padron, R. I., Ley, K., Reiser, J., and Gupta, V. (2011) Small molecule-mediated activation of the integrin CD11b/CD18 reduces inflammatory disease. Sci. Signal. 4, ra57
46. Park, J. Y., Arnaout, M. A., and Gupta, V. (2007) A simple, no-wash cell adhesion-based high throughput assay for the discovery of small molecule regulators of the integrin CD11b/CD18. J. Biomol. Screen. 12, 406-417
47. You, T. J., Maxwell, D. S., Kogan, T. P., Chen, Q., Li, J., Kassir, J., Holland, G. W., and Dixon, R. A. (2002) A 3D structure model of integrin α4β1 complex: I. Construction of a homology model of β1 and ligand binding analysis. Biophys. J. 82, 447-457
48. Zhu, J., Zhu, J., Negri, A., Provasi, D., Filizola, M., Coller, B. S., and Springer, T. A. (2010) Closed headpiece of integrin αIIbβ3 and its complex with an αIIbβ3-specific antagonist that does not induce opening. Blood 116, 5050-5059
49. Lin, Kc., Ateeq, H. S., Hsiung, S. H., Chong, L. T., Zimmerman, C. N., Castro, A., Lee, W. C., Hammond, C. E., Kalkunte, S., Chen, L. L., Pepinsky, R. B., Leone, D. R., Sprague, A. G., Abraham, W. M., Gill, A., Lobb, R. R., and Adams, S. P. (1999) Selective, tight-binding inhibitors of integrin α4β1 that inhibit allergic airway responses. J. Med. Chem. 42, 920-934
50. Nowlin, D. M., Gorcsan, F., Moscinski, M., Chiang, S. L., Lobl, T. J., and Cardarelli, P. M. (1993) A novel cyclic pentapeptide inhibits α4β1 and α5β1 integrin-mediated cell adhesion. J. Biol. Chem. 268, 20352-20359
51. Shimaoka, M., and Springer, T. A. (2003) Therapeutic antagonists and conformational regulation of integrin function. Nat. Rev. Drug Discov. 2, 703-716
52. Lu, C., Shimaoka, M., Salas, A., and Springer, T. A. (2004) The binding sites for competitive antagonistic, allosteric antagonistic, and agonistic antibodies to the I domain of integrin LFA-1. J. Immunol. 173, 3972-3978
53. Asaumi, N., Omoto, E., Mahmut, N., Katayama, Y., Takeda, K., Shinagawa, K., and Harada, M. (2001) Very late antigen-5 and leukocyte functionassociated antigen-1 are critical for early stage hematopoietic progenitor cell homing. Ann. Hematol. 80, 387-392
54. Bougie, D. W., Wilker, P. R., Wuitschick, E. D., Curtis, B. R., Malik, M., Levine, S., Lind, R. N., Pereira, J., and Aster, R. H. (2002) Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa. Blood 100, 2071-2076